CA2

Thyroid tumor marker

Calcitonin

Calcitonin is a hormone that is primarily used as a tumor marker in medullary thyroid cancer. It is produced in the C cells of the thyroid gland and can also be elevated in other neuroendocrine tumors, such as pheochromocytoma and endocrine tumors of the pancreas and intestines.

Calcitonin is a hormone that is mainly produced by the C cells (parafollicular cells) of the thyroid gland. The hormone plays a role in the body's calcium and phosphate metabolism by inhibiting bone resorption and lowering calcium levels in the blood. In healthy adults, calcitonin has relatively limited physiological significance, but it is an important biomarker in the diagnosis of certain endocrine tumors, especially medullary thyroid cancer.

Calcitonin is clinically valuable in suspected medullary thyroid cancer, but elevated concentrations can also occur in other neuroendocrine tumors such as pheochromocytoma, endocrine pancreatic tumor and endocrine intestinal tumor. The analysis is used both for diagnosis, monitoring after treatment and in genetic screening of families with hereditary medullary cancer (MEN2 syndrome).

What can cause an elevated calcitonin level?

An elevated calcitonin level is often a sign of pathological conditions, especially tumors originating from neuroendocrine cells. Here are some causes of elevated calcitonin levels:

Medullary thyroid cancer: The most important clinical cause of high calcitonin. Elevated levels are seen in both sporadic and hereditary forms of this cancer.

Pheochromocytoma: A hormone-producing tumor in the adrenal medulla that can cause elevated calcitonin in the presence of MEN2 syndrome.

Endocrine pancreatic tumors: Some neuroendocrine tumors in the pancreas can cause elevated calcitonin.

Endocrine intestinal tumors: Tumors of the gastrointestinal tract that produce hormonal substances, including calcitonin.

Renal failure: In chronic renal failure, calcitonin levels in the blood may be slightly elevated, indicating that the kidneys have a reduced ability to eliminate the hormone from the bloodstream. In addition, some patients with renal failure may develop secondary hyperparathyroidism and disturbed calcium-phosphate balance, which may indirectly affect calcitonin production.

Symptoms of high calcitonin

Elevated calcitonin levels themselves rarely cause direct symptoms, but can indicate underlying diseases with their own characteristic signs:

  • Thyroid nodule (in medullary thyroid cancer)
  • Sweating, palpitations, headache (in pheochromocytoma)
  • Diarrhea and abdominal pain (can be seen in certain endocrine tumors)
  • Nervousness, high blood pressure (associated with neuroendocrine syndromes)

Note that the symptoms depend on the type and extent of the underlying tumor, not on the calcitonin itself.

What can a low calcitonin value mean?

Low concentrations of calcitonin are normal and usually have no clinical significance. In contrast, low or undetectable levels after surgical treatment of medullary thyroid cancer are a good indication that the disease is under control or in remission.

After thyroidectomy: After removal of the thyroid gland, the source of calcitonin disappears, leading to very low levels.

No detectable disease: Normal or low values ​​usually indicate the absence of neuroendocrine tumors.

Other effects of calcitonin

Although calcitonin in humans is not essential for calcium regulation, it acts by inhibiting osteoclast activity in the skeleton, thereby reducing bone resorption. It may therefore play some role in bone metabolism, especially in conditions of elevated calcium. In medical therapy, synthetic calcitonin is sometimes used to treat conditions such as osteoporosis, hypercalcemia, and Paget's disease, although its use has declined due to better alternatives.

Reference range for S-Calcitonin

Men: below 3.5 pmol/L

Women: below 1.5 pmol/L

Interpretation in tumor diagnostics

Values ​​above 20 pmol/L are strongly suspected of medullary thyroid cancer and should be investigated further. In the case of slightly elevated levels between 5–10 ng/L, follow-up, stimulation tests and additional imaging diagnostics may be necessary to rule out tumor.

Tests containing the marker Calcitonin

Tumor markers

Tumor markers


CA2
Tumor marker in medullary thyroid cancer

S-Calcitonin

  • Analysis of S-Calcitonin in the blood.
  • Blood test for suspected thyroid cancer.
  • In the investigation of medullary thyroid cancer.
  • High values ​​can be seen in neuroendocrine tumors.

1 495 kr